Trial intelligence / Profile preview

SPADE: Polyhexanide vs Mupirocin and Chlorhexidine for Preoperative S. Aureus Decolonization

NCT06633588Phase 4Completed

Sponsor
Swiss Paraplegic Research
Start
May 2025
Primary completion
Jun 2026
Modality
Polymer-based Nanoparticles, Small Molecules
Countries
1
01

Overview

A Phase 4 trial of polihexanide in Staphylococcus aureus colonization, sponsored by Swiss Paraplegic Research. Started May 2025; status: completed.

02

Drugs

polihexanide
03

Conditions

Staphylococcus aureus colonization

Beyond the preview

Go deeper on NCT06633588.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06633588.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call